SCHEMBL27797644

SCHEMBL27797644

C=CC(=O)Nc1ccc(-c2cc(Nc3ccc(Oc4ccccc4)cc3)ncn2)cc1N

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BTK Q06187 8/20 0.53
EGFR P00533 6/20 0.53
KCNH2 Q12809 1/20 0.51
ERBB2 P04626 2/20 0.51
JAK3 P52333 6/20 0.49
JAK2 O60674 4/20 0.49
JAK1 P23458 4/20 0.49
TGM2 P21980 1/20 0.48
ABL1 P00519 2/20 0.44
BCR P11274 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
MAP2K7 O14733 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL690318 0.81 TGM2 (0.71) BTKEGFRKCNH2ERBB2JAK3
SCHEMBL691113 0.77 EGFR (0.67) BTKEGFRKCNH2ERBB2JAK3
SCHEMBL12262344 0.75 EGFR (0.57) BTKEGFRKCNH2ERBB2JAK3
Ammonia Solution, Strong SCHEMBL27797645 0.74 ABL1 (0.57) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL692807 0.72 EGFR (0.68) BTKEGFRKCNH2ERBB2JAK3
SCHEMBL690536 0.71 MAP2K7 (0.69) BTKEGFRKCNH2ERBB2JAK3
SCHEMBL20138980 0.71 EGFR (0.67) BTKEGFRKCNH2ERBB2TGM2
SCHEMBL3488790 0.70 EGFR (0.51) BTKEGFRKCNH2ERBB2JAK3
SCHEMBL4114739 0.70 ABL1 (0.60) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL3488793 0.70 EGFR (0.51) BTKEGFRKCNH2ERBB2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105367503-A HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS INC 2016-03-02 CN disclosed
CN-101902911-B Heteroaryl compounds and uses thereof AVILA THERAPEUTICS, INC. (US) 2015-12-16 CN disclosed
CN-101902911-A Heteroaryl compounds and uses thereof AVILA THERAPEUTICS INC 2010-12-01 CN disclosed